Advertisement
Advertisement
U.S. markets open in 2 hours 20 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Precipio, Inc. (PRPO)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.3600-0.0700 (-4.90%)
At close: 04:00PM EST
1.4000 +0.04 (+2.94%)
After hours: 07:53PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close1.4300
Open1.4200
Bid0.0000 x 1100
Ask0.0000 x 1000
Day's Range1.3500 - 1.4700
52 Week Range1.3500 - 9.1800
Volume100,093
Avg. Volume432,385
Market Cap30.883M
Beta (5Y Monthly)2.45
PE Ratio (TTM)N/A
EPS (TTM)-0.3570
Earnings DateMar 29, 2022 - Apr 04, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for PRPO

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Precipio, Inc.
    Analyst Report: QIAGEN N.V.Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates over 85% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (44% of 2020 sales), followed by EMEA (36%) and Asia-Pacific (19%).
    Rating
    Fair Value
    Economic Moat
    7 days agoMorningstar
View more
  • InvestorPlace

    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

    Welcome back, trader! I hope you got your rest out over the holiday weekend because we’re starting off Monday with the biggest pre-market stock movers! Source: Eric Urquhart/Shutterstock.com Moving stocks this morning is Omicron Covid-19 news, falls following rallies, and more. Let’s get right into that news below!InvestorPlace - Stock Market News, Stock Advice & Trading Tips Pre-Market Stock Movers: 10 Top Gainers Petros Pharmaceuticals (NASDAQ:PTPI) stock is rocketing more than 72% in what app

  • GlobeNewswire

    New York State Approves Precipio’s HemeScreen for POL clinical use

    New York Cancer & Blood POL will commence the use of HemeScreen in its laboratoryNEW HAVEN, Conn., Nov. 18, 2021 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) announces that its HemeScreen RUO assay has received the required approval from New York State’s Department of Health (NY DOH). Hemescreen can now be used by New York based physician-owned laboratories (POLs) who apply to run HemeScreen in their lab as a laboratory-developed test (LDT). New York Sta

  • GlobeNewswire

    89bio Announces Appointment of Kathy LaPorte to its Board of Directors

    SAN FRANCISCO, Nov. 03, 2021 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases, today announced the appointment of Kathy LaPorte to its Board of Directors, effective immediately. Ms. LaPorte brings deep expertise and valuable experience in the industry to the Company. "It is a pleasure to welcome Kathy, an esteemed industry lea

Advertisement
Advertisement